NO995014D0 - Direkte ekspresjon av peptider i dyrkingsmedia - Google Patents

Direkte ekspresjon av peptider i dyrkingsmedia

Info

Publication number
NO995014D0
NO995014D0 NO995014A NO995014A NO995014D0 NO 995014 D0 NO995014 D0 NO 995014D0 NO 995014 A NO995014 A NO 995014A NO 995014 A NO995014 A NO 995014A NO 995014 D0 NO995014 D0 NO 995014D0
Authority
NO
Norway
Prior art keywords
direct expression
peptides
culture media
producing
glycine
Prior art date
Application number
NO995014A
Other languages
English (en)
Other versions
NO995014L (no
NO327325B1 (no
Inventor
Nozar M Mehta
Martha V L Ray
Christopher P Meenan
Angelo P Consalvo
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Publication of NO995014D0 publication Critical patent/NO995014D0/no
Publication of NO995014L publication Critical patent/NO995014L/no
Publication of NO327325B1 publication Critical patent/NO327325B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/71Expression systems using regulatory sequences derived from the trp-operon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/72Expression systems using regulatory sequences derived from the lac-operon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO19995014A 1997-04-16 1999-10-14 Ekspresjonsvektor, vertcelle samt fremgangsmate for fremstilling av et peptidprodukt. NO327325B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4370097P 1997-04-16 1997-04-16
PCT/US1998/007723 WO1998046722A1 (en) 1997-04-16 1998-04-15 Direct expression of peptides into culture media

Publications (3)

Publication Number Publication Date
NO995014D0 true NO995014D0 (no) 1999-10-14
NO995014L NO995014L (no) 1999-12-13
NO327325B1 NO327325B1 (no) 2009-06-08

Family

ID=21928441

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995014A NO327325B1 (no) 1997-04-16 1999-10-14 Ekspresjonsvektor, vertcelle samt fremgangsmate for fremstilling av et peptidprodukt.

Country Status (14)

Country Link
US (5) US6103495A (no)
EP (2) EP2088188B1 (no)
JP (2) JP4907751B2 (no)
AT (2) ATE522598T1 (no)
AU (1) AU742270B2 (no)
CA (1) CA2285658C (no)
DE (1) DE69841939D1 (no)
DK (2) DK1005526T3 (no)
ES (1) ES2375330T3 (no)
HU (1) HUP0001272A3 (no)
LT (1) LT4701B (no)
NO (1) NO327325B1 (no)
RU (1) RU2218407C2 (no)
WO (1) WO1998046722A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2218407C2 (ru) * 1997-04-16 2003-12-10 Юниджен Лэбораториз Инк. Прямая экспрессия пептидов в культуральные среды
KR100385298B1 (ko) * 2000-09-05 2003-05-23 한국생명공학연구원 단백질 생산방법
US7166575B2 (en) * 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
TW200411053A (en) 2002-12-30 2004-07-01 Ind Tech Res Inst Nucleic acid encoding recombinant salmon calcitionin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US20050215476A1 (en) * 2004-01-21 2005-09-29 Unigene Laboratories Inc. Amidated parathyroid hormone fragments and uses thereof
US8227241B2 (en) * 2004-03-12 2012-07-24 Unigene Laboratories, Inc. Bacterial host cell for the direct expression of peptides
US7648965B2 (en) * 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7531518B2 (en) * 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
US7445911B2 (en) * 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
WO2006130806A2 (en) * 2005-06-01 2006-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Assay for agonists and antagonists of ion channels and for regulators of genetic expression
WO2006132925A2 (en) * 2005-06-01 2006-12-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
JP4856177B2 (ja) 2005-06-24 2012-01-18 ユニジーン・ラボラトリーズ・インコーポレーテッド アミド化生成物の調製に有用な酵素を発現させるための細胞株
KR101193722B1 (ko) 2006-07-24 2013-01-11 바이오렉시스 파마슈티칼 코포레이션 엑센딘 융합 단백질
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
RU2370280C2 (ru) * 2007-10-08 2009-10-20 Институт физико-химической биологии им. А.Н.Белозерского СПОСОБ СУПЕРПРОДУКЦИИ В РАСТЕНИИ АНТИТЕЛ ПРОТИВ ОНКОГЕНА HER2/neu
US9422559B2 (en) 2010-06-02 2016-08-23 Shi-Lung Lin Production and utilization of a novel anti-cancer drug in therapy
US9399773B2 (en) 2012-08-10 2016-07-26 Shi-Lung Lin Production and extraction of MicroRNA precursor as drug for cancer therapy
JP5753097B2 (ja) 2009-01-22 2015-07-22 ユニジーン・ラボラトリーズ・インコーポレーテッド 肥満の治療
CN103764669B (zh) 2011-06-15 2017-08-15 雷索特制药公司 抗炎药物产品
WO2013025248A1 (en) 2011-08-12 2013-02-21 Mello Biotechnology, Inc. Inducable expression from the eukaryotic pol -2 promoter in prokaryotes
CN103998052B (zh) 2011-11-02 2016-08-17 关键生物科学有限公司 用于治疗疾病和紊乱的肽类似物
ES2673617T3 (es) 2011-11-02 2018-06-25 Keybioscience Ag Miméticos de calcitonina para tratar enfermedades y trastornos
US10414808B2 (en) 2012-05-18 2019-09-17 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
US9102751B2 (en) * 2012-05-18 2015-08-11 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
US10196662B2 (en) 2012-08-10 2019-02-05 Mello Biotechnology, Inc. Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors
CA2904327C (en) 2013-03-05 2021-06-08 Enteris Biopharma, Inc. Pharmaceuticals for oral delivery
MX2016004282A (es) 2013-10-03 2016-10-12 Janssen Biotech Inc Variantes de protoxina-ii y metodos de uso.
LT3321278T (lt) 2013-11-14 2019-03-12 Keybioscience Ag Kalcitonino mimetikai, skirti ligų ir sutrikimų gydymui
CN103709236B (zh) * 2013-12-23 2015-04-15 江南大学 一种可提高分泌效率的信号肽及其应用
KR102294577B1 (ko) 2015-01-12 2021-08-26 엔터리스 바이오파마, 인크. 고체 경구 제형
MA41642A (fr) 2015-03-03 2018-01-09 Janssen Biotech Inc Variants de protoxine ii et méthodes d'utilisation
WO2016161100A1 (en) 2015-04-02 2016-10-06 Janssen Biotech, Inc. Protoxin-ii variants and methods of use
WO2017095458A1 (en) 2015-12-02 2017-06-08 Chih-Li Lin A COMPOSITION AND METHOD OF USING miR-302 PRECURSORS AS DRUGS FOR TREATING ALZHEIMER'S DISEASES
JP2018535684A (ja) 2015-12-02 2018-12-06 リン、シー−ランLIN, Shi−Lung CD34陽性成体幹細胞の増殖を誘導する薬物としてのmicroRNA前駆体の使用
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB202001024D0 (en) 2020-01-24 2020-03-11 Key Bioscience Ag Oxyntomodulin mimetics

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332664A (en) * 1981-07-15 1994-07-26 Celltech Limited Human calcitonin precursor polyprotein structural gene
US4595658A (en) * 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4962055A (en) * 1983-03-08 1990-10-09 Rikagaku Kenkyusho Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
US6319685B1 (en) * 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
US4708934A (en) 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US5747281A (en) * 1984-09-28 1998-05-05 Cornell Research Foundation, Inc. System useful for the production of proteins from recombinant DNA in single celled organisms
ATE78515T1 (de) * 1984-10-05 1992-08-15 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
DE3632037A1 (de) 1986-09-20 1988-04-07 Hoechst Ag Gentechnisches verfahren zur herstellung von salm-calcitonin sowie mittel zur durchfuehrung dieses verfahrens
US5089406A (en) * 1987-01-07 1992-02-18 Allied-Signal Inc. Method of producing a gene cassette coding for polypeptides with repeating amino acid sequences
US4946790A (en) * 1987-02-06 1990-08-07 Mitsui Toatsu Chemicals, Inc. Recombinant plasmid for the expression of L-phenylalanine ammonia-lyase and transformed strain carrying same
US5789234A (en) 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US5223407A (en) 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JP2551399B2 (ja) * 1989-08-15 1996-11-06 株式会社資生堂 C末端アミド化に関与する酵素並びにその製造方法及びその使用
US5240831A (en) * 1991-01-10 1993-08-31 Board Of Regents, The University Of Texas Methods and compositions for the expression of biologically active eukaryotic cytochrome p45os in bacteria
US5547862A (en) * 1993-07-29 1996-08-20 Ambion Inc. Vectors containing multiple promoters in the same orientation
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
RU2218407C2 (ru) * 1997-04-16 2003-12-10 Юниджен Лэбораториз Инк. Прямая экспрессия пептидов в культуральные среды

Also Published As

Publication number Publication date
AU742270B2 (en) 2001-12-20
CA2285658C (en) 2011-10-04
US6737250B2 (en) 2004-05-18
CA2285658A1 (en) 1998-10-22
HUP0001272A1 (hu) 2000-08-28
US7968311B2 (en) 2011-06-28
EP2088188A1 (en) 2009-08-12
EP1005526A1 (en) 2000-06-07
LT99133A (en) 2000-04-25
US6103495A (en) 2000-08-15
US20010055789A1 (en) 2001-12-27
EP2088188B1 (en) 2011-08-31
RU2218407C2 (ru) 2003-12-10
WO1998046722A9 (en) 1999-11-18
JP2002501379A (ja) 2002-01-15
WO1998046722A1 (en) 1998-10-22
US6210925B1 (en) 2001-04-03
DK2088188T3 (da) 2012-01-02
US6627438B2 (en) 2003-09-30
JP4907751B2 (ja) 2012-04-04
ATE522598T1 (de) 2011-09-15
JP2012024108A (ja) 2012-02-09
EP1005526A4 (en) 2005-02-09
US20040191865A1 (en) 2004-09-30
US20020045211A1 (en) 2002-04-18
DK1005526T3 (da) 2011-02-07
ES2375330T3 (es) 2012-02-28
LT4701B (lt) 2000-09-25
NO995014L (no) 1999-12-13
JP5634971B2 (ja) 2014-12-03
HUP0001272A3 (en) 2012-12-28
NO327325B1 (no) 2009-06-08
DE69841939D1 (de) 2010-11-25
ATE484572T1 (de) 2010-10-15
EP1005526B1 (en) 2010-10-13
AU7127998A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
NO995014L (no) Direkte ekspresjon av peptider i dyrkingsmedia
DK1013765T4 (da) Fremgangsmåde til frembringelse af L-aminosyrer
DE69730514D1 (de) Amidase
KR850001288A (ko) 아프로티닌 동족체의 제조방법
DE69210645D1 (de) Verfahren zur Herstellung von cysteinfreien Peptiden
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
DE60231055D1 (de) Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie
ATE234933T1 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
CA2260365A1 (en) Differentiation-suppressive polypeptide
DE60313866D1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
ATE209179T1 (de) Asymmetrische synthese von chiralen beta- aminosäuren
EP0683233A3 (en) Process for producing recombinant human serum albumin
ZA976353B (en) Deformylation of f-met peptides in bacterial expression
ATE122099T1 (de) Verfahren zur herstellung von c-terminalen alpha- amidierten peptiden.
ATE78872T1 (de) Herstellung von polypeptiden.
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
DE69623803D1 (de) Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
Sugie et al. Purification and some properties of D-amino acids-specific peptidase from Nocardia orientalis.
ATE236982T1 (de) Klonierung und expression eines neuen glukoamylasegens aus endomyces fibuliger
TH17635EX (th) อะมิโนเพพติเดสชนิดใหม่ กระบวนการเตรียมอะมิโนเพพติเดสและโปรตีนจากมัน
TH17635A (th) อะมิโนเพพติเดสชนิดใหม่ กระบวนการเตรียมอะมิโนเพพติเดสและโปรตีนจากมัน
DK1318198T3 (da) Fremgangsmåde til fremstilling af et rekombinant polypeptid under tilsætning af en inhibitor for chymotrypsin til cellekulturmediet

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees